.png?width=1280&auto=webp&quality=80&format=jpg&disable=upscale)
glp 1 for sleep apnea Will GLP-1 Drugs Disrupt the Market? Episode 75- GLP 1 drugs
Description
A patient doesnt need to learn how to take a pill, but self-injection requires instruction
The adults segment dominated the GLP-1 targeted peptide weight loss drugs market in 2024 because obesity prevalence is highest among adults, making them the primary target population for these therapies
Injection site reactions and gastrointestinal symptoms were common adverse effects
6 June 2025
Only in the case of liraglutide did the comparator medications include sitagliptin and exenatide
Biochem Pharmacol (2012) 83(8):1084103
